Press releases

image of papers

Key Capital Strengthens Vaccine Patents

NEW YORK, NY, February 18, 2021 – KEY CAPITAL CORPORATION (OTC Pink: KCPC) advises that it continues to work with Immunitor, its partner and Licensor, to progress further research and development of its breakthrough therapeutic vaccines, and for several unique supplements.

Read More »
image of papers

Key Capital to Distribute Novel Immune Supplement

NEW YORK, NY, January 28, 2021 – KEY CAPITAL CORPORATION (OTC Pink: KCPC) advises that as SARS-CoV-2 continues to spread, and reports of increases in daily infections, hospitalizations, and deaths are becoming regular, Key Capital plans to market its Immunitor partnered potentially therapeutic oral pill as a supplement commencing early February.

Read More »